carvedilol has been researched along with epirubicin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Basar, E; Cetinkaya, Y; Dogan, A; Er, O; Ergin, A; Eryol, NK; Inanc, T; Kalay, N; Oguzhan, A; Ozdogru, I; Topsakal, R | 1 |
| Han, YL; Liang, XF; Liu, L; Liu, YY; Liu, ZZ; Xie, XD; Zheng, ZD | 1 |
1 review(s) available for carvedilol and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for carvedilol and epirubicin
| Article | Year |
|---|---|
Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anthracyclines; Antibiotics, Antineoplastic; Blood Flow Velocity; Carbazoles; Cardiomyopathies; Carvedilol; Coronary Circulation; Diastole; Doxorubicin; Echocardiography, Doppler; Epirubicin; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Neoplasms; Propanolamines; Single-Blind Method; Stroke Volume; Systole; Ventricular Function, Left | 2006 |
[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Breast Neoplasms; Carbazoles; Carvedilol; Chemotherapy, Adjuvant; Cyclophosphamide; Electrocardiography; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Radical; Middle Aged; Propanolamines; Stroke Volume; Tetrazoles; Troponin | 2013 |
3 other study(ies) available for carvedilol and epirubicin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |